Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00050791 · ClinicalTrials.gov registry record · Phase 2
Effects of Leptin Treatment on Weight Loss
A Phase 2 study, sponsored by Rockefeller University.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT00050791 is a Phase 2 study that has completed, run by Rockefeller University. The registered enrollment target is 40 participants.
The verdict
NCT00050791, a Phase 2 study, has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a double blind placebo controlled clinical study designed to determine the effects of leptin on the changes that occur in the body during weight loss achieved by a very low calorie diet.
Interventions
- DRUG Leptin
- BEHAVIORAL Very Low Calorie Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2001-03 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00050791
The ClinicalTrials.gov registry entry for NCT00050791 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Leptin is the first listed.
NCT00050791 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00050791 about?
NCT00050791 is a clinical study titled "Effects of Leptin Treatment on Weight Loss". This is a double blind placebo controlled clinical study designed to determine the effects of leptin on the changes that occur in the body during weight loss achieved by a very low calorie diet.
What is the current status of trial NCT00050791?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2001-03. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00050791?
The interventions under investigation include: Leptin (DRUG), Very Low Calorie Diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT00050791?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.